Five Alarm Bio seeking funding to develop drugs targeting the chronic diseases of ageing
Live Forever Club - 12-Feb-2025Promising preclinical results suggest a clear path towards drug development
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Company that develops drugs to slow down the ageing process
Visit website: http://www.fivealarmbio.com/
Details last updated 07-Nov-2020
Promising preclinical results suggest a clear path towards drug development
FAB1 compound reduces ageing markers in cells while FAB15 accelerates wound healing
No drug candidates yet, but great to see investors willing to support a broad attack on ageing
The company aims at treatments for a range of diseases associated with ageing and disabilities
Professor of Molecular Biogerontology at University of Birmingham Institute of Inflammation and Ageing, consultant, futurist, speaker